Study Stopped
Low rate of recruitment (only one patient up to May 2014)
Liver Transplantation in Alcoholic Hepatitis
SETH-HA
Applicability of Liver Transplantation in Alcoholic Hepatitis
1 other identifier
observational
40
1 country
17
Brief Summary
Patients with alcoholic hepatitis non-responsive to steroids have a poor prognosis. Recently a French-Belgian prospective study has obtained good results (acceptable survival with a low rate of alcohol recidivism). The hypothesis of the present study is that carefully selected Spanish patients with alcoholic hepatitis that do not respond to steroid therapy may have a good survival if they receive a liver transplant. The expected rate of alcohol recidivism in such a selected population will be low.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2013
Longer than P75 for all trials
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedFirst Posted
Study publicly available on registry
January 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJune 3, 2014
June 1, 2014
1.9 years
December 29, 2012
June 2, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate survival of patients with severe alcoholic hepatitis non responsive to therapy after liver transplantation
The survival of patients transplanted with alcoholic hepatitis is going to be compared with the survival of patients with alcoholic hepatitis that are not considered adequate for liver transplantation
1 year after the diagnosis of alcoholic hepatitis
Secondary Outcomes (4)
Evaluate the applicability of liver transplantation in patients with alcoholic hepatitis non responsive to steroid therapy
1 year
Evaluate the mortality in waiting list for transplantation of patients with alcoholic hepatitis unresponsive to steroid therapy
1 year
Evaluate the rate of alcohol recidivism after liver transplantation for alcoholic hepatitis
1, 2, 3, 4 and 5 years
Evaluate survival of patients with alcoholic hepatitis after liver transplantation.
2, 3, 4 and 5 years after the diagnosis of alcoholic hepatitis
Study Arms (3)
Good response
Patients with severe alcoholic hepatitis and good response to therapy.
Non transplant candidates
Patients with severe alcoholic hepatitis and poor response to therapy, that are not candidates to transplantation, according to the specified criteria.
Transplant candidates
Patients with severe alcoholic hepatitis and poor response to therapy, that are candidates to transplantation, according to the specified criteria.
Eligibility Criteria
Patients with alcoholic hepatitis participating in this trial are going to be selected from patients admitted to the hospital (from the emergency department or referred from other hospital)
You may qualify if:
- Diagnosis of alcoholic hepatitis (liver biopsy will be advisable).
- First episode of clinical decompensation of alcoholic liver disease (defined as jaundice, variceal bleeding, ascites or portal-systemic encephalopathy).
- Absence of a high risk of alcoholic recidivism (according to De Gottardi, et al).
- Severe alcoholic hepatitis (ABIC score \> 6.71)
- Informed consent
You may not qualify if:
- Age over 65 years.
- Hepatitis B or C or HIV infections.
- Uncontrolled bacterial infection
- Other liver diseases, such as alpha-1-antitrypsin deficiency, primary biliary cirrhosis, ...
- Morbid obesity (BMI \> 35 kg/m2)
- Major uncontrolled psychiatric disease
- Drug addiction (excluding tobacco) in the last two years.
- Absence of informed consent.
- Acute-on-chronic liver disease.
- Paracetamol consumption over 10 grams in the last week.
- Criteria for liver transplantation.
- Absence of response to steroid therapy (Lille score ≥ 0.45 7 days after initiation of steroid therapy).
- Adequate social and familiar environment.
- Complete agreement in the medical staff about the candidate to transplantation.
- Absence of bacterial or fungal infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
Hospital Vall d'Hebrón
Barcelona, Barcelona, Spain
Hospital Marqués de Valdecilla
Santander, Cantabria, Spain
Hospital Reina Sofía
Córdoba, Córdoba, Spain
Hospital Virgen de la Nieves
Granada, Granada, Spain
Complejo Hospitalario Universitario de la Coruña
A Coruña, La Coruña, Spain
Hospital Clínico Universitario de Santiago
Santiago de Compostela, La Coruña, Spain
Hospital Gregorio Marañón
Madrid, Madrid, Spain
Hospital Ramón y Cajal
Madrid, Madrid, Spain
Hospital Puerta de Hierro
Majadahonda, Madrid, Spain
Hospital Virgen de la Arrixaca
Murcia, Murcia, Spain
Hospital Carlos Haya
Málaga, Málaga, Spain
Clínica Universidad de Navarra
Pamplona, Navarre, Spain
Hospital Central de Asturias
Oviedo, Principality of Asturias, Spain
Hospital Virgen del Rocío
Seville, Sevilla, Spain
Hospital La Fe
Valencia, Valencia, Spain
Hospital Río Hortega
Valladolid, Valladolid, Spain
Hospital Lozano Blesa
Zaragoza, Zaragoza, Spain
Related Publications (4)
Dominguez M, Rincon D, Abraldes JG, Miquel R, Colmenero J, Bellot P, Garcia-Pagan JC, Fernandez R, Moreno M, Banares R, Arroyo V, Caballeria J, Gines P, Bataller R. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008 Nov;103(11):2747-56. doi: 10.1111/j.1572-0241.2008.02104.x. Epub 2008 Aug 21.
PMID: 18721242BACKGROUNDTome S, Martinez-Rey C, Gonzalez-Quintela A, Gude F, Brage A, Otero E, Abdulkader I, Forteza J, Bustamante M, Varo E. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol. 2002 Jun;36(6):793-8. doi: 10.1016/s0168-8278(02)00047-8.
PMID: 12044530BACKGROUNDWells JT, Said A, Agni R, Tome S, Hughes S, Dureja P, Lucey MR. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation. Liver Transpl. 2007 Dec;13(12):1728-35. doi: 10.1002/lt.21298.
PMID: 18044757BACKGROUNDMathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, Castel H, Duhamel A, Pageaux GP, Leroy V, Dharancy S, Louvet A, Boleslawski E, Lucidi V, Gustot T, Francoz C, Letoublon C, Castaing D, Belghiti J, Donckier V, Pruvot FR, Duclos-Vallee JC. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011 Nov 10;365(19):1790-800. doi: 10.1056/NEJMoa1105703.
PMID: 22070476BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ignacio Herrero, MD
Clinica Universidad de Navarra
- STUDY CHAIR
Santiago Tome, MD
Complejo Hospitalario Universitario de Santiago
- STUDY CHAIR
Ignacio Gonzalez-Pinto, MD
Hospital Central de Asturias
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2012
First Posted
January 15, 2013
Study Start
January 1, 2013
Primary Completion
December 1, 2014
Study Completion
December 1, 2017
Last Updated
June 3, 2014
Record last verified: 2014-06